Showing all 2 results
Cinnarizine & Dimenhydrinate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Immediate-Release Tablet, packed exclusively in secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the active antihistamine salts.
Active Ingredient Strength Primary Clinical Function Cinnarizine BP/USP 20 mg The Peripheral Stabilizer: Stops the influx of calcium into the inner ear hair cells to dampen the physical sensation of vertigo. Dimenhydrinate BP/USP 40 mg The Central Antiemetic: Blocks H1 and muscarinic receptors in the brain to prevent nausea and motion-induced vomiting. Excipients Microcrystalline Cellulose / Maize Starch / Talc / Magnesium Stearate / Croscarmellose Sodium Diluent / Binder / Glidant / Superdisintegrant (Engineered specifically utilizing High-Shear Dry Blending to ensure 100% uniformity of the active APIs, providing a rapid disintegration profile that delivers relief within 30 minutes of ingestion). *Pack Sizes: 10×10 Blisters (Optimized specifically for short-course acute vertigo regimens).
Cinnarizine Tablets
FreeTechnical & Manufacturing Specifications
Formulated for consistent release kinetics and long-term chemical stability.
Technical Metric Specification Standard Active Ingredient Cinnarizine BP / USP / IP Dosage Form Immediate Release Tablets Available Strengths 25 mg (Vestibular) / 75 mg (Cerebrovascular) HS Code 3004.90.39 (Other CNS drugs) / 2933.59.90 Stability Validated for Zone IVb (Tropical) export markets
